Rite Aid (RAD) February Comps Up 3.1%
Tweet
Share
E-mailGet Alerts RAD Hot Sheet
Join SI Premium – FREE
Rite Aid Corporation (NYSE: RAD) reports sales for February increased 2.3 percent to $2.551 billion compared to $2.495 billion for the same period last year. Comps rose 3.1 percent.
Prescription sales accounted for 68.3 percent of drugstore sales, and third party prescription sales represented 96.7 percent of pharmacy sales.
Quarterly Sales
Same store sales for the 14-week period ended March 3, 2012 increased 3.0 percent over the prior-year period. Front-end same store sales increased 1.6 percent while pharmacy same store sales increased 3.8 percent. Prescription count at comparable stores increased 2.4 percent over the prior-year period.
Total drugstore sales for the 14-week period increased 2.5 percent with sales of $7.118 billion compared to $6.947 billion for the same period last year. Prescription sales represented 67.4 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.
Year End Sales
Same store sales for the 53-week period ended March 3, 2012 increased 2.0 percent, consisting of a 1.1 percent front-end same store sales increase and a 2.4 percent increase in pharmacy same store sales. Prescriptions filled at comparable stores increased 0.9 percent over the prior-year period.
Total drugstore sales for the 53 weeks ended March 3, 2012 increased 1.5 percent to $26.019 billion from $25.633 billion in last year’s like period. Prescription sales accounted for 68.1 percent of total drugstore sales, and third party prescription sales represented 96.5 percent of pharmacy sales.
Prescription sales accounted for 68.3 percent of drugstore sales, and third party prescription sales represented 96.7 percent of pharmacy sales.
Quarterly Sales
Same store sales for the 14-week period ended March 3, 2012 increased 3.0 percent over the prior-year period. Front-end same store sales increased 1.6 percent while pharmacy same store sales increased 3.8 percent. Prescription count at comparable stores increased 2.4 percent over the prior-year period.
Total drugstore sales for the 14-week period increased 2.5 percent with sales of $7.118 billion compared to $6.947 billion for the same period last year. Prescription sales represented 67.4 percent of total drugstore sales, and third party prescription sales represented 96.6 percent of pharmacy sales.
Year End Sales
Same store sales for the 53-week period ended March 3, 2012 increased 2.0 percent, consisting of a 1.1 percent front-end same store sales increase and a 2.4 percent increase in pharmacy same store sales. Prescriptions filled at comparable stores increased 0.9 percent over the prior-year period.
Total drugstore sales for the 53 weeks ended March 3, 2012 increased 1.5 percent to $26.019 billion from $25.633 billion in last year’s like period. Prescription sales accounted for 68.1 percent of total drugstore sales, and third party prescription sales represented 96.5 percent of pharmacy sales.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Radiopharm raises up to $13M via US and Australian offerings
- Jaguar Uranium hires advisor firm, adds retired general to board
- Rosenblatt Assumes Seagate Technology (STX) at Buy, 'entering a period of pricing-driven upward estimate revisions'
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
